AdvantiGen Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- AdvantiGen Biosciences's estimated annual revenue is currently $1.1M per year.
- AdvantiGen Biosciences's estimated revenue per employee is $155,000
Employee Data
- AdvantiGen Biosciences has 7 Employees.
- AdvantiGen Biosciences grew their employee count by 17% last year.
AdvantiGen Biosciences's People
Name | Title | Email/Phone |
---|---|---|
1 | Business Development Executive | Reveal Email/Phone |
2 | Marketing Specialist | Reveal Email/Phone |
AdvantiGen Biosciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2.8M | 18 | 20% | N/A | N/A |
#2 | $1.9M | 12 | 33% | N/A | N/A |
#3 | $1.1M | 7 | 0% | N/A | N/A |
#4 | $0.9M | 6 | 0% | N/A | N/A |
#5 | $5.2M | 67 | 0% | $45.5M | N/A |
#6 | $1.4M | 9 | 0% | N/A | N/A |
#7 | $1.6M | 10 | 0% | N/A | N/A |
#8 | $1.1M | 7 | 17% | N/A | N/A |
#9 | $13.5M | 87 | -17% | N/A | N/A |
#10 | $0.6M | 4 | -20% | N/A | N/A |
What Is AdvantiGen Biosciences?
AdvantiGen specializes in the tracking of proteins and cells in vitro and in vivo using the Infrared (IR) region of the spectrum. Our IR optical imaging products allow the visualization of biological events in real time and the non-invasive imaging of both in vivo and ex vivo animal models. AdvantiGen’s IR products have lower background which results in dramatic improvements in both research and diagnostic imaging. The primary goals of AdvantiGen are to produce products that enable drug discovery, that lead to the development of diagnostics and that support basic and clinical research.
keywords:N/AN/A
Total Funding
7
Number of Employees
$1.1M
Revenue (est)
17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.6M | 7 | 0% | N/A |
#2 | $1.1M | 7 | 0% | N/A |
#3 | $1.1M | 7 | 17% | N/A |
#4 | $0.5M | 7 | N/A | N/A |
#5 | $0.5M | 7 | 0% | N/A |